Приказ основних података о документу

dc.creatorČebzan, Alen
dc.creatorRužić, Dušan
dc.creatorNikolić, Katarina
dc.date.accessioned2023-08-02T08:42:32Z
dc.date.available2023-08-02T08:42:32Z
dc.date.issued2023
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/4952
dc.language.isoensr
dc.publisherEuropean Association for Cancer Research
dc.rightsrestrictedAccesssr
dc.sourceEACR-Boehringer Ingelheim Drugging and Regulating the MAP Kinase Pathway Virtual Event, Worldwide : 21 - 22 February 2023sr
dc.subject3D-QSAR modelsr
dc.subjectMAPK inhibitorssr
dc.subjectdescriptorssr
dc.subjectdockingsr
dc.subjectpyrimidine — pyridonesr
dc.subjectpyrazolyl-pymolesr
dc.subjectligandsr
dc.subjectBebpebed bal inin basedsr
dc.subjectstructure basedsr
dc.subjectcancersr
dc.titleComputer-aided drug design of MAPK inhibitors by combined 3D-QSAR analysis and molecular dockingsr
dc.typeconferenceObjectsr
dc.rights.licenseARRsr
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_farfar_4952
dc.type.versionpublishedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу